Research report: Patient perspectives on cardioprotective medication during breast cancer treatment
Research report: Patient perspectives on cardioprotective medication during breast cancer treatment Bioengineer.org
Онкология
🎗️
Главное · Новое
Commentary: I want a cure for brain tumors, so I’m going to vote for it
Commentary: I want a cure for brain tumors, so I’m going to vote for it Colorado Newsline
🎗️Лента новостей
Онкология
Blood test offers new way to track lung cancer
Northwestern Medicine scientists and collaborators have demonstrated a novel liquid biopsy technique that can measure cancer burden and reveal molecular characteristics of small cell lung cancer (SCLC), according to a new study published in the Journal of Clinical Investigation.
Онкология
‘Robust’ response from sofetabart mipitecan in ovarian cancer
At current standard of care, less than half of women with recurrent platinum sensitive ovarian cancer who have had prior treatment with poly(ADP-ribose) polymerase inhibitors respond to subsequent therapy. Phase 1 data presented at European Society for Medical Oncology Congress showed treatment with sofetabart…
Онкология
Key Updates in GU Oncology From ESMO 2026
Key Updates in GU Oncology From ESMO 2026 Oncodaily
Онкология
HHS further loosens restrictions for several peptides
HHS has taken action to expand access to six peptides that were key in a controversial meeting this summer. The interim enforcement policy states that, based on the Pharmacy Compounding Advisory Committee (PCAC) meeting that took place in July, “HHS believes that there is significant interest in the use of these…
Онкология
Healthy diet may lower heart disease risk after cancer
Eating a healthy diet is associated with a reduced risk of heart disease and death among cancer survivors, according to a study published today in JACC: Advances.
Онкология
Antibody candidate could help preserve appetite and muscle strength in patients with cancer
In cancer cachexia, patients continue to lose weight, muscle and fat even when they eat. A KAIST research team has developed a therapeutic candidate that blocks a signal responsible for appetite suppression, weight loss and excessive energy expenditure.
🎗️
Онкология
Targeted drug shrinks tumors in 3 out of 4 patients with advanced breast cancer
Targeted drug shrinks tumors in 3 out of 4 patients with advanced breast cancer 930 WFMD Free Talk
Онкология
What’s New On Radiotherapy of Prostate Cancer in 2026?
What’s New On Radiotherapy of Prostate Cancer in 2026? Oncodaily
Онкология
Insurance Approval Leaves Gaps in Oral Blood Cancer Treatment Access
Insurance Approval Leaves Gaps in Oral Blood Cancer Treatment Access Pharmacy Times
Онкология
Rille Pihlak: New Science, New Friendships and New Hope for Cancer Patients
Rille Pihlak: New Science, New Friendships and New Hope for Cancer Patients Oncodaily
Онкология
PHERGain Five-Year Results: Chemotherapy-Free HER2-Positive Breast Cancer Treatment Shows Durable Outcomes as ctDNA Refines Risk Assessment
PHERGain Five-Year Results: Chemotherapy-Free HER2-Positive Breast Cancer Treatment Shows Durable Outcomes as ctDNA Refines Risk Assessment Oncodaily